Original articleIxekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3
Key words
Abbreviations used
Cited by (0)
Funding sources: Supported by Eli Lilly and Company.
Disclosure: Dr Egeberg has received research funding from Pfizer, Eli Lilly and Company, the Danish National Psoriasis Foundation, and the Kgl Hofbundtmager Aage Bangs Foundation, as well as honoraria for serving as a consultant and/or speaker from Leo Pharma, Samsung Bioepis, Pfizer, Eli Lilly and Company, Novartis, Galderma, and Janssen Pharmaceuticals. Dr Wu has served as an investigator for AbbVie, Amgen, Eli Lilly and Company, Janssen, Novartis, and Regeneron. Dr Solomon has served as a consultant for and/or received honoraria from Eli Lilly and Company, Genentech, Castle Biosciences, and Samumed, and he is an employee of Ameriderm Research, which has received clinical trial grants from Allergan, Altana, Anacor, Apotex, AstraZeneca, Asubio, Barrier, Basilea, Bayer, Boehringer Ingelheim, Biocryst, Braintree, Centocor, Celtic, Chilter, Cipher, Clynsis, Concentrics, Covance, CuTech, Dermira, Dow, Eli Lilly and Company, Encorium, Epithany, Galderma, Genentech, Genomics, GlaxoSmithKline, Glenmark, Health Decisions, HedgePath Pharmaceutical, Hill, ICON, Incyte, Inventiv, Kendle International, Leo Pharmaceuticals, Manhattan, Maruho, MAVIS, Merck, Novartis, Noven, Novum, Omnicare, ParaPro Inc, Parexel, Peplin, Pfizer, PharmaNet, Polynoma, PPD Development, PRA, Premier, Pro Trials, Quintiles, Regeneron, Research Sample Bank, Rho, Roche, Sanofi-Aventis, SciQuus, Serentis, SGS, Steifel, Sterling Bio, Symbio, Taisho, Taro, Teva, Theraputics, TKL Research, Tolmar, Topaz, Vanda, and Worldwide Clinical Trials. Dr Korman has served as an investigator, grant reviewer, speaker or advisory board member for Abbvie, Amgen, Dermira, Celgene, Eli Lilly and Company, Janssen, Merck, Novartis, Pfizer, Prothena, Regeneron, Sun, and Valeant. Drs Goldblum, Zhao, and Mallbris are full-time employees of Eli Lilly and Company and own stock in it.
This manuscript was prepared with the assistance of a medical writer who is a full-time employee of Eli Lilly and Company.
Portions of the results reported in this manuscript were previously presented in the form of an abstract and poster at the American Academy of Dermatology 75th Annual Meeting, Orlando, FL, March 5, 2017.